Transplanted functional islet mass: Donor, islet preparation, and recipient factors influence early graft function in islet-after-kidney patients

Transplantation

Volumn 93, Issue 6, 2012, Pages 632-638

  Friberg, Andrew S ^{a,b,c,d,e,f,g}   Lundgren, Torbjörn ^h   Malm, Helene ^h   Felldin, Marie ^h   Nilsson, Bo ^h   Jenssen, Trond ^h   Kyllönen, Lauri ^h   Tufveson, Gunnar ^h   Tibell, Annika ^h   Korsgren, Olle ^h  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c University Hospital   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f UNIVERSITY OF TROMSØ   (Norway)

^g HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^h NONE

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CREATININE; DACLIZUMAB; GLUCOSE; INSULIN; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DONOR; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENGRAFTMENT; FEMALE; GRAFT RECIPIENT; GRAFT REJECTION; HUMAN; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PANCREAS ISLET TRANSPLANTATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; RETROSPECTIVE STUDY; SEX DIFFERENCE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; C-PEPTIDE; CELLS, CULTURED; COLD ISCHEMIA; CREATININE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GRAFT SURVIVAL; HUMANS; INSULIN; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; ORGAN SIZE; QUALITY CONTROL; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION; TREATMENT OUTCOME;

EID: 84858699016     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3182455912     Document Type: Article

References (0)